Todd Foley's Net Worth
Estimate Recalculated Jun 18, 2025 08:33PM EST
Who is Todd Foley
Todd Foley does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., iTeos Therapeutics, Inc., TriVascular Technologies, Inc., Entrada Therapeutics, Inc., Repare Therapeutics Inc., Dyne Therapeutics, Inc., Celladon Corp, Verastem, Inc., Syndax Pharmaceuticals Inc, Harpoon Therapeutics, Inc., ARATANA THERAPEUTICS, INC., TCR2 THERAPEUTICS INC., Conatus Pharmaceuticals Inc, TURMERIC ACQUISITION CORP., Epizyme, Inc., Werewolf Therapeutics, Inc., Cerecor Inc., Oncorus, Inc., Radius Health, Inc., Zalicus Inc., CHIASMA, INC, and Pacira Pharmaceuticals, Inc..
SEC CIK
Todd Foley's CIK is 0001473930
Past Insider Trading and Trends
2010 was Todd Foley's most active year for acquiring shares with 2 total transactions. Todd Foley's most active month to acquire stocks was the month of May. 2021 was Todd Foley's most active year for disposing of shares, totalling 5 transactions. Todd Foley's most active month to dispose stocks was the month of July. 2022 saw Todd Foley paying a total of $0.00 for 60,918 shares, this is the most they've acquired in one year. In 2021 Todd Foley cashed out on 62,000 shares for a total of $0.00, their largest year based on trade value.
No data available
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
